Novartis Ag (NVS)
NYSE:NVS
US Market
Advertisement

Novartis (NVS) Ratios

Compare
3,834 Followers

Novartis Ratios

NVS's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, NVS's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.88 1.16 1.29 1.51 0.90
Quick Ratio
0.68 0.93 1.04 1.29 0.68
Cash Ratio
0.30 0.51 0.26 0.41 0.29
Solvency Ratio
0.32 0.43 0.24 0.46 0.17
Operating Cash Flow Ratio
0.66 0.55 0.50 0.50 0.41
Short-Term Operating Cash Flow Coverage
2.80 2.38 2.40 2.39 1.39
Net Current Asset Value
$ -34.34B$ -22.71B$ -21.12B$ -18.25B$ -45.72B
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.26 0.24 0.24 0.29
Debt-to-Equity Ratio
0.72 0.56 0.47 0.46 0.67
Debt-to-Capital Ratio
0.42 0.36 0.32 0.31 0.40
Long-Term Debt-to-Capital Ratio
0.34 0.28 0.25 0.25 0.32
Financial Leverage Ratio
2.42 2.14 1.98 1.95 2.33
Debt Service Coverage Ratio
2.41 2.56 1.97 2.11 1.26
Interest Coverage Ratio
15.66 11.43 10.99 33.23 11.68
Debt to Market Cap
0.12 0.12 0.14 0.16 0.18
Interest Debt Per Share
16.84 13.10 13.20 14.23 17.09
Net Debt to EBITDA
0.98 0.71 1.39 1.09 1.86
Profitability Margins
Gross Profit Margin
76.21%73.27%70.12%69.99%69.70%
EBIT Margin
31.08%21.38%15.39%22.13%20.35%
EBITDA Margin
40.54%39.19%28.41%32.40%30.53%
Operating Profit Margin
31.15%20.94%17.75%50.96%20.35%
Pretax Profit Margin
29.13%19.55%16.15%49.43%19.80%
Net Profit Margin
25.53%31.83%13.42%45.43%16.18%
Continuous Operations Profit Margin
25.51%18.37%11.67%16.41%14.83%
Net Income Per EBT
87.66%162.78%83.08%91.90%81.72%
EBT Per EBIT
93.51%93.39%91.02%96.99%97.30%
Return on Assets (ROA)
13.42%14.86%5.92%18.23%6.11%
Return on Equity (ROE)
34.12%31.82%11.72%35.51%14.26%
Return on Capital Employed (ROCE)
23.32%13.28%10.36%26.53%10.25%
Return on Invested Capital (ROIC)
18.51%11.49%8.05%22.90%7.61%
Return on Tangible Assets
27.31%29.86%12.31%35.32%12.37%
Earnings Yield
5.50%7.08%3.71%12.94%3.97%
Efficiency Ratios
Receivables Turnover
6.27 5.74 5.80 5.99 5.50
Payables Turnover
2.94 2.53 3.01 2.86 2.80
Inventory Turnover
2.09 2.11 2.16 2.38 2.12
Fixed Asset Turnover
4.70 4.27 4.25 4.03 3.58
Asset Turnover
0.53 0.47 0.44 0.40 0.38
Working Capital Turnover Ratio
-11.77 7.56 4.36 8.72 -46.50
Cash Conversion Cycle
108.95 92.44 110.75 86.54 108.08
Days of Sales Outstanding
58.17 63.55 62.93 60.94 66.37
Days of Inventory Outstanding
174.74 173.05 169.11 153.34 172.13
Days of Payables Outstanding
123.96 144.16 121.29 127.74 130.42
Operating Cycle
232.91 236.60 232.04 214.28 238.50
Cash Flow Ratios
Operating Cash Flow Per Share
10.71 6.96 6.53 6.72 5.99
Free Cash Flow Per Share
9.30 5.64 5.30 5.40 4.86
CapEx Per Share
1.41 1.33 1.22 1.32 1.14
Free Cash Flow to Operating Cash Flow
0.87 0.81 0.81 0.80 0.81
Dividend Paid and CapEx Coverage Ratio
1.99 1.44 1.40 1.46 1.43
Capital Expenditure Coverage Ratio
7.60 5.25 5.33 5.07 5.28
Operating Cash Flow Coverage Ratio
0.66 0.55 0.51 0.48 0.36
Operating Cash Flow to Sales Ratio
0.37 0.31 0.27 0.29 0.27
Free Cash Flow Yield
7.18%5.58%6.18%6.52%5.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.16 14.12 26.92 7.73 25.21
Price-to-Sales (P/S) Ratio
4.52 4.49 3.61 3.51 4.08
Price-to-Book (P/B) Ratio
5.90 4.49 3.16 2.74 3.60
Price-to-Free Cash Flow (P/FCF) Ratio
13.93 17.91 16.19 15.34 18.39
Price-to-Operating Cash Flow Ratio
12.40 14.50 13.15 12.32 14.91
Price-to-Earnings Growth (PEG) Ratio
-0.79 0.11 -0.38 0.04 1.87
Price-to-Fair Value
5.90 4.49 3.16 2.74 3.60
Enterprise Value Multiple
12.14 12.18 14.10 11.93 15.22
Enterprise Value
277.45B 222.65B 207.70B 204.31B 231.87B
EV to EBITDA
12.14 12.18 14.10 11.93 15.22
EV to Sales
4.92 4.77 4.01 3.86 4.65
EV to Free Cash Flow
15.16 19.02 17.96 16.88 20.96
EV to Operating Cash Flow
13.17 15.40 14.59 13.56 16.99
Tangible Book Value Per Share
-5.00 -1.67 -0.70 1.80 -4.45
Shareholders’ Equity Per Share
22.53 22.47 27.21 30.17 24.86
Tax and Other Ratios
Effective Tax Rate
0.12 0.06 0.17 0.08 0.18
Revenue Per Share
28.65 22.47 23.76 23.58 21.91
Net Income Per Share
7.31 7.15 3.19 10.71 3.54
Tax Burden
0.88 1.63 0.83 0.92 0.82
Interest Burden
0.94 0.91 1.05 2.23 0.97
Research & Development to Revenue
0.19 0.24 0.19 0.18 0.18
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.01
Income Quality
1.47 1.69 2.05 0.63 1.69
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis